Subclinical nephrosclerosis is linked to left ventricular hypertrophy independent of classical atherogenic factors

Hypertension Research

Volumn 37, Issue 5, 2014, Pages 472-477

  Haruyama, Naoki ^a   Tsuchimoto, Akihiro ^a   Masutani, Kosuke ^a   Nagata, Masaharu ^a   Kitada, Hidehisa ^a   Tanaka, Masao ^a   Tsuruya, Kazuhiko ^a   Kitazono, Takanari ^a  

^a KYUSHU UNIVERSITY   (Japan)

Author keywords

cardio renal interaction; global glomerulosclerosis; nephrosclerosis

Indexed keywords

CHOLESTEROL;

ADULT; AGE; ARTICLE; ATHEROGENESIS; CARDIOVASCULAR RISK; CHOLESTEROL BLOOD LEVEL; DIABETES MELLITUS; DISEASE ASSOCIATION; ECHOCARDIOGRAPHY; FEMALE; GENDER; GLOMERULOSCLEROSIS; GLOMERULUS FILTRATION RATE; HEART LEFT VENTRICLE HYPERTROPHY; HEART LEFT VENTRICLE MASS; HEART VENTRICLE REMODELING; HIGH RISK POPULATION; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; KIDNEY BIOPSY; KIDNEY DONOR; KIDNEY FUNCTION; LIVING DONOR; MALE; MEDICAL HISTORY; PREVALENCE; RETROSPECTIVE STUDY; SYSTOLIC BLOOD PRESSURE; AGED; BLOOD PRESSURE; COMPLICATION; HYPERTENSION; HYPERTROPHY, LEFT VENTRICULAR; KIDNEY; MIDDLE AGED; NEPHROSCLEROSIS; PATHOPHYSIOLOGY; PHYSIOLOGY; RISK FACTOR;

ADULT; AGED; BLOOD PRESSURE; FEMALE; GLOMERULAR FILTRATION RATE; HUMANS; HYPERTENSION; HYPERTROPHY, LEFT VENTRICULAR; KIDNEY; MALE; MIDDLE AGED; NEPHROSCLEROSIS; RISK FACTORS;

EID: 84899799041     PISSN: 09169636     EISSN: 13484214     Source Type: Journal    
DOI: 10.1038/hr.2013.154     Document Type: Article

References (34)

1. Tsioufis C, Kokkinos P, Macmanus C, Thomopoulos C, Faselis C, Doumas M, Stefanadis C, Papademetriou V. Left ventricular hypertrophy as a determinant of renal outcome in patients with high cardiovascular risk. J Hypertens 2010; 28: 2299-2308
2. Leoncini G, Viazzi F, Parodi D, Vettoretti S, Ratto E, Ravera M, Tomolillo C, Del Sette M, Bezante GP, Deferrari G, Pontremoli R. Mild renal dysfunction and subclinical cardiovascular damage in primary hypertension. Hypertension 2003; 42: 14-18
3. Agarwal S, Thohan V, Shlipak MG, Lima J, Bluemke DA, Siscovick D, Gomes A, Herrington DM. Association between Cystatin C and MRI measures of left ventricular structure and function: Multi Ethnic study of atherosclerosis. Int J Nephrol 2011; 2011: 153868
4. Fesler P, Du Cailar G, Ribstein J, Mimran A. Left ventricular remodeling and renal function in never-Treated essential hypertension. J Am Soc Nephrol 2003; 14: 881-887
5. Fogo AB. Mechanisms in nephrosclerosis and hypertension-beyond hemodynamics. J Nephrol 2001; 14(Suppl 4), S63-S69
6. Kubo M, Kiyohara Y, Kato I, Tanizaki Y, Katafuchi R, Hirakata H, Okuda S, Tsuneyoshi M, Sueishi K, Fujishima M, Iida M. Risk factors for renal glomerular and vascular changes in an autopsy-based population survey: The Hisayama Study. Kidney Int 2003; 63: 1508-1515
7. Rule AD, Amer H, Cornell LD, Taler SJ, Cosio FG, Kremers WK, Textor SC, Stegall MD. The Association between age and nephrosclerosis on renal biopsy among healthy adults. Ann Intern Med 2010; 152: 561-567
8. Ribstein J, Du Cailar G, Zanchetti A. Cardiac and renal damage in the elderly hypertensive. J Renin Angiotensin Aldosterone Syst 2002; 3(Suppl 1), S16-S24
9. Devereux RB, Alonso DR, Lutas EM, Gottlieb GJ, Campo E, Sachs I, Reichek N. Echocardiographic assessment of left ventricular hypertrophy: Comparison to necropsy findings. Am J Cardiol 1986; 57: 450-458
10. Mancia G, De Baker G, Dominiczak A, Cifkova R, Fagard R, Germanò G, Grassi G, Heagerty AM, Kjeldsen SE, Laurent S, Narkiewicz K, Ruilope L, Rynkiewicz A, Schmieder RE, Boudier HA, Zanchetti A, Vahanian A, Camm J, De Caterina R, Dean V, Dickstein K, Filippatos G, Funck-Brentano C, Hellemans I, Kristensen SD, McGregor K, Sechtem U, Silber S, Tendera M, Widimsky P, Zamorano JL, Erdine S, Kiowski W, Agabiti-Rosei E, Ambrosion E, Fagard R, Lindholm LH, Manolis A, Nilsson PM, Redon J, Viigimaa M, Adamopoulos S, Agabiti-Rosei E, Bertomeu V, Clement D, Farsang C, Gaita D, Lip G, Mallion JM, Manolis AJ, Nilsson PM, O'Brien E, Ponikowski P, Ruschitzka F, Tamargo J, van Zwieten P, Viigimaa M, Waeber B, Williams B, Zamorano JL. 2007 Guidelines for the management of arterial hypertension: The task force for the management of arterial hypertension of the European Society of Hypertension (ESH) and the European Society of Cardiology (ESC). J Hypertens 2007; 25: 1105-1187
11. Muntner P, Krousel-Wood M, Hyre AD, Stanley E, Cushman WC, Cutler JA, Piller LB, Goforth GA, Whelton PK. Antihypertensive prescriptions for newly treated patients before and after the main antihypertensive and lipid-lowering treatment to prevent heart attack trial results and seventh report of the joint national committee on prevention, detection, evaluation, and treatment of high blood pressure guidelines. Hypertension 2009; 53: 617-623
12. Committee of Japanese diabetes society on the diagnosis criteria of diabetes mellitus. Report of the committee on the classification and diagnostic criteria of diabetes mellitus. J Jpn Diabetes Soc 2010; 53: 450-467
13. Du Bois D, Du Bois EF. A formula to estimate the approximate surface area if height and weight be known. Arch Intern Med 1916; 17: 863-871
14. Racusen LC, Solez K, Colvin RB, Bonsib SM, Castro MC, Cavallo T, Croker BP, Demetris AJ, Drachenberg CB, Fogo AB, Furness P, Gaber LW, Gibson IW, Glotz D, Goldberg JC, Grande J, Halloran PF, Hansen HE, Hartley B, Hayry PJ, Hill CM, Hoffman EO, Hunsicker LG, Lindblad AS, Yamaguchi Y. The Banff 97 working classification of renal allograft pathology. Kidney Int 1999; 55: 713-723
15. Li Q, Li Z, Zheng G, Gao G, Yu K. Rank-Based Robust Tests for Quantitative-Trait Genetic Association Studies. Genet Epidemiol 2013; 37: 358-365
16. Zheng G, Yang Y, Zhu X, Elston RC. Analysis of Genetic Association Studies. Gail M, Krickeberg K, Samet J, Tsiatis A and Wong W (eds). Statistics for Biology and Health. Springer, New York, NY, USA, 2012, PP 61-93
17. Nakano T, Ninomiya T, Sumiyoshi S, Fujii H, Doi Y, Hirakata H, Tsuruya K, Iida M, Kiyohara Y, Sueishi K. Association of kidney function with coronary atherosclerosis and calcification in autopsy samples from japanese elders: The Hisayama Study. Am J Kidney Dis 2010; 55: 21-30
18. Remuzzi G, Perico N, Macia M, Ruggenenti P. The role of renin-Angiotensinaldosterone system in the progression of chronic kidney disease. Kidney Int Suppl 2005; 99: S57-S65
19. Chen Y, Lipkowitz MS, Salem RM, Fung MM, Bhatnagar V, Mahata M, Nievergelt CM, Rao F, Mahata SK, Schork NJ, Hicks PJ, Bowden DW, Freedman BI, Brophy VH, OConnor DTAASK. Progression of chronic kidney disease: Adrenergic genetic influence on glomerular filtration rate decline in hypertensive nephrosclerosis. Am J Nephrol 2010; 32: 23-30
20. Imakiire T, Kikuchi Y, Yamada M, Kushiyama T, Higashi K, Hyodo N, Yamamoto K, Oda T, Suzuki S, Miura S. Effects of renin-Angiotensin system blockade on macrophage infiltration in patients with hypertensive nephrosclerosis. Hypertens Res 2007; 30: 635-642
21. Ono H, Ono Y, Takanohashi A, Matsuoka H, Frohlich ED. Apoptosis and glomerular injury after prolonged nitric oxide synthase inhibition in spontaneously hypertensive rats. Hypertension 2001; 38: 1300-1306
22. London GM. Left ventricular hypertrophy: Why does it happen?. Nephrol Dial Transplant 2003; 18 (Suppl 8), viii2-viii6
23. Pedrinelli R, Dell'Omo G, Di Bello V, Pellegrini G, Pucci L, Del Prato S, Penno G. Low-grade inflammation and microalbuminuria in hypertension. Arterioscler Thromb Vasc Biol 2004; 24: 2414-2419
24. Pitt B, Reichek N, Willenbrock R, Zannad F, Phillips RA, Roniker B, Kleiman J, Krause S, Burns D, Williams GH. Effects of eplerenone, enalapril, and eplerenone/enalapril in patients with essential hypertension and left ventricular hypertrophy: The 4E-left ventricular hypertrophy study. Circulation 2003; 108: 1831-1838
25. Schlaich MP, Kaye DM, Lambert E, Sommerville M, Socratous F, Esler MD. Relation between cardiac sympathetic activity and hypertensive left ventricular hypertrophy. Circulation 2003; 108: 560-565
26. Nardi E, Palermo A, Mulè G, Cusimano P, Cottone S, Cerasola G. Left ventricular hypertrophy and geometry in hypertensive patients with chronic kidney disease. J Hypertens 2009; 27: 633-641
27. Chade AR, Lerman A, Lerman LO. Kidney in early atherosclerosis. Hypertension 2005; 45: 1042-1049
28. Rothermund L, Lorenz M, Schnieber A, Eberson J, Bauhaus I, Bernhard Haug M, Schulz A, Keller F, Vetter R, Kreutz R. Impact of nephron number dosing on cardiorenal damage and effects of ACE inhibition. Am J Hypertens 2010; 24: 474-481
29. Singh RR, Denton KM, Bertram JF, Jefferies AJ, Head GA, Lombardo P, Schneider-Kolsky M, Moritz KM. Development of cardiovascular disease due to renal insufficiency in male sheep following fetal unilateral nephrectomy. J Hypertens 2009; 27: 386-396
30. Hollenberg NK, Adams DF, Solomon HS, Rashid A, Abrams HL, Merrill JP. Senescence and the renal vasculature in normal man. Circ Res 1974; 34: 309-316
31. Watanabe S, Okura T, Liu J, Miyoshi K, Fukuoka T, Hiwada K, Higaki J. Serum cystatin C level is a marker of end-organ damage in patients with essential hypertension. Hypertens Res 2003; 26: 895-899
32. Perticone F, Maio R, Ruberto C, Cassano S, Tripepi G, Perticone M, Sesti G, Zoccali C. Kidney function and risk factors for left ventricular hypertrophy in untreated uncomplicated essential hypertension. Am J Kidney Dis 2008; 52: 74-84
33. Ito S. Cardiorenal connection in chronic kidney disease. Clin Exp Nephrol 2012; 16: 8-16
34. Kasiske BL. Relationship between vascular disease and age-Associated changes in the human kidney. Kidney Int 1987; 31: 1153-1159